Samik Pharm Co

Samik Pharm Co EBIT per Share

The EBIT per Share of Samik Pharm Co (014950.KQ) as of Oct 19, 2026 is 356.86 KRW. In the previous year, EBIT per Share was 514.44 KRW — a change of -30.63% (lower).

EBIT per Share

356.86KRW

YoY

-30.63%

Last updated:

EBIT per Share of Samik Pharm Co is 2025 356.86 KRW. EBIT per Share of Samik Pharm Co was 2024 514.44 KRW. It decreases by -30.63% lower compared to the previous year.

The Samik Pharm Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
304.88 KRW
Jan 1, 2024
514.44 KRW
Jan 1, 2025
356.86 KRW
The Samik Pharm Co EBIT per Share history
YEAREBIT per ShareYoY
356.86KRW-30.63%
514.44KRW+68.73%
304.88KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Samik Pharm Co Stock analysis

What does Samik Pharm Co do? Samik Pharm Co Ltd is a company based in Incheon, South Korea, with an upcoming IPO scheduled for October 27, 2025. The company operates within the pharmaceutical industry, focusing on the manufacturing and sales of various pharmaceutical products. Its product portfolio includes medications for circulatory system treatments, such as Cesar Plus and Eravix tablets, diabetes management solutions like Griffin and Gluemser tablets, digestive system treatments including Samik Pharmotidine and Rebacode tablets, and antipyretic anti-inflammatory drugs such as Tamitrasemi and Seklfen tablets. The company also produces drugs for treating acute or recurrent vaginal candidiasis, motion sickness in children, and alopecia. Samik Pharm Co Ltd distributes its products both domestically within South Korea and internationally. The company's website is https://www.samik.co.kr/. It is listed under the ticker 014950.KQ with ISIN KR7014950000. The company is headquartered in Incheon, South Korea, and is engaged in the production and sale of pharmaceuticals. Samik Pharm Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Samik Pharm Co stock

EBIT per Share of Samik Pharm Co is 356.86 KRW in 2025.

EBIT per Share of Samik Pharm Co changed from 514.44 KRW to 356.86 KRW, representing a -30.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Samik Pharm Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Samik Pharm Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Samik Pharm Co